ReviewCurrent opinion in structural biology2026
Altered residence time as a cause of drug resistance.
Review in Current opinion in structural biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Drug-target residence time is a crucial determinant of pharmacological efficacy, complementing traditional equilibrium affinity measures. Variations in residence time influence drug selectivity, therapeutic windows, and resistance development, yet its molecular underpinnings remain incompletely understood. Here we review factors governing residence time, including kinetic parameters and structural influences, and examine how mutations can alter dissociation rates to confer drug resistance. We highlight recent advances in experimental and computational methods, such as molecular dynamics simulations, that enable prediction and rational design of compounds with optimized residence times. These insights underscore the importance of incorporating kinetic considerations into drug discovery to improve efficacy and overcome resistance. Our findings suggest that optimizing residence time offers a promising strategy to enhance therapeutic outcomes for diverse diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.